Publications by authors named "Angela Luttick"

Claim this Profile
N
N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19) .
Michaela Lackner, Annika Rössler, André Volland, Marlena Nastassja Stadtmüller, Brigitte Müllauer, Angela Luttick

Emerg Microbes Infect· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a single-step, single-tube reverse transcription loop-mediated isothermal amplification assay for rapid detection of SARS-CoV-2 RNA.
Jean Y H Lee, Nickala Best, Julie McAuley, Jessica L Porter, Torsten Seemann, Angela Luttick

J Med Microbiol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sars-CoV-2 (COVID-19) inactivation capability of copper-coated touch surface fabricated by cold-spray technology.
Novana Hutasoit, Byron Kennedy, Stephanie Hamilton, Angela Luttick, Rizwan Abdul Rahman Rashid

Manuf Lett· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prodrugs of imidazotriazine and pyrrolotriazine C-nucleosides can increase anti-HCV activity and enhance nucleotide triphosphate concentrations in vitro.
Edward M Tyndall, Alistair G Draffan, Barbara Frey, Brett Pool, Rosliana Halim, Angela Luttick

Bioorg Med Chem Lett· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of 1,2,3,9b-tetrahydro-5H-imidazo[2,1-a]isoindol-5-ones as a new class of respiratory syncytial virus (RSV) fusion inhibitors. Part 1.
Silas Bond, Alistair G Draffan, Jennifer E Fenner, John Lambert, Chin Yu Lim, Angela Luttick

Bioorg Med Chem Lett· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1,2,3,9b-Tetrahydro-5H-imidazo[2,1-a]isoindol-5-ones as a new class of respiratory syncytial virus (RSV) fusion inhibitors. Part 2: identification of BTA9881 as a preclinical candidate.
Silas Bond, Alistair G Draffan, Jennifer E Fenner, John Lambert, Chin Yu Lim, Angela Luttick

Bioorg Med Chem Lett· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Derivatives of imidazotriazine and pyrrolotriazine C-nucleosides as potential new anti-HCV agents.
Alistair G Draffan, Barbara Frey, Benjamin H Fraser, Brett Pool, Carlie Gannon, Angela Luttick

Bioorg Med Chem Lett· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of drug-resistant influenza virus A(H1N1) and A(H3N2) variants selected in vitro with laninamivir.
Mélanie Samson, Yacine Abed, François-Marc Desrochers, Stephanie Hamilton, Angela Luttick

Antimicrob Agents Chemother· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A zanamivir dimer with prophylactic and enhanced therapeutic activity against influenza viruses.
E Bart Tarbet, Stephanie Hamilton, Almut H Vollmer, Angela Luttick, Wy Ching Ng

J Antimicrob Chemother· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Synthesis of C-Nucleosides as Potential New Anti-HCV Agents.
Alistair G Draffan, Barbara Frey, Brett Pool, Carlie Gannon, Edward M Tyndall, Angela Luttick

ACS Med Chem Lett· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methods to determine mechanism of action of anti-influenza inhibitors.
Angela Luttick, Stephanie Hamilton, Simon P Tucker

Methods Mol Biol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Orally Available 3-Ethoxybenzisoxazole Capsid Binder with Clinical Activity against Human Rhinovirus.
Susanne C Feil, Stephanie Hamilton, Guy Y Krippner, Bo Lin, Angela Luttick

ACS Med Chem Lett· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Ethoxybenzoxazole as a bioisosteric replacement of an ethyl benzoate group in a human rhinovirus (HRV) capsid binder.
Renee N Brown, Rachel Cameron, David K Chalmers, Stephanie Hamilton, Angela Luttick

Bioorg Med Chem Lett· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase.
Keith G Watson, Rachel Cameron, Rob J Fenton, David Gower, Stephanie Hamilton, Angela Luttick

Bioorg Med Chem Lett· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural characterization of respiratory syncytial virus fusion inhibitor escape mutants: homology model of the F protein and a syncytium formation assay.
Craig J Morton, Rachel Cameron, Lynne J Lawrence, Bo Lin, Melinda Lowe, Angela Luttick

Virology· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirus.
Keith G Watson, Renee N Brown, Rachel Cameron, David K Chalmers, Stephanie Hamilton, Angela Luttick

J Med Chem· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of contaminating adenovirus type 1 in the ATCC reference strain of respiratory syncytial virus A2 (VR-1302).
Rachel Cameron, Charles Buck, Denise Merrill, Angela Luttick

Virus Res· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis